Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hemostatic Forceps Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Hemostatic Forceps Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Industry: Medical Devices & Consumables
Published Date: 2024-04-17
Pages: 207 Pages
Report ld: 2700530
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemostatic Forceps Market Size(US$)
CAGR 2024-2030
4.3%
Market Size,2030
USD 81
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 63 million
Market Forecast in 2030(Value)
US$ 81 million
CAGR
4.3%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
The global Hemostatic Forceps market size was US$ 60 million in 2023 and is forecast to a readjusted size of US$ 81 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030.
Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.
In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.
In terms of sales (consumption) side, this report focuses on the sales of Hemostatic Forceps by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Hemostatic Forceps market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Hemostatic Forceps market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
By Company
- Medline
- B. Braun
- CareFusion
- Asa Dental
- Sklar
- Scanlan International
- Shanghai Medical Instruments
- Lawton
- Hu-Friedy
- Xinhua Surgical
- Towne Brothers
- Teleflex Medical
- Delacroix Chevalier
- YDM
- M A Corporation
- MedGyn Products
- Inami
- Ted Pella
- Medicon eG
- J & J Instruments
- American Diagnostic
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Halstead Mosquito Hemostatic Forceps
- Kelly and Crile Hemostatic Forceps
- Rochester-Carmalt Hemostatic Forceps
Segment by Application
- Surgical
- Dissection
- Dental
- Laparoscopic
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hemostatic Forceps in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Hemostatic Forceps manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemostatic Forceps sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Hemostatic Forceps Definition
1.2 Market by Type
1.2.1 Global Hemostatic Forceps Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Halstead Mosquito Hemostatic Forceps
1.2.3 Kelly and Crile Hemostatic Forceps
1.2.4 Rochester-Carmalt Hemostatic Forceps
1.3 Market Segment by Application
1.3.1 Global Hemostatic Forceps Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Surgical
1.3.3 Dissection
1.3.4 Dental
1.3.5 Laparoscopic
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Hemostatic Forceps Sales
2.1 Global Hemostatic Forceps Revenue Estimates and Forecasts 2019-2030
2.2 Global Hemostatic Forceps Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Hemostatic Forceps Revenue by Region
2.3.1 Global Hemostatic Forceps Revenue by Region (2019-2024)
2.3.2 Global Hemostatic Forceps Revenue by Region (2025-2030)
2.4 Global Hemostatic Forceps Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Hemostatic Forceps Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Hemostatic Forceps Sales Quantity by Region
2.6.1 Global Hemostatic Forceps Sales Quantity by Region (2019-2024)
2.6.2 Global Hemostatic Forceps Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Hemostatic Forceps Sales Quantity by Manufacturers
3.1.1 Global Hemostatic Forceps Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Hemostatic Forceps Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Hemostatic Forceps Sales in 2023
3.2 Global Hemostatic Forceps Revenue by Manufacturers
3.2.1 Global Hemostatic Forceps Revenue by Manufacturers (2019-2024)
3.2.2 Global Hemostatic Forceps Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Hemostatic Forceps Revenue in 2023
3.3 Global Hemostatic Forceps Sales Price by Manufacturers
3.4 Global Key Players of Hemostatic Forceps, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hemostatic Forceps Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hemostatic Forceps, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hemostatic Forceps, Product Offered and Application
3.8 Global Key Manufacturers of Hemostatic Forceps, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Hemostatic Forceps Sales Quantity by Type
4.1.1 Global Hemostatic Forceps Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Hemostatic Forceps Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Hemostatic Forceps Sales Quantity Market Share by Type (2019-2030)
4.2 Global Hemostatic Forceps Revenue by Type
4.2.1 Global Hemostatic Forceps Historical Revenue by Type (2019-2024)
4.2.2 Global Hemostatic Forceps Forecasted Revenue by Type (2025-2030)
4.2.3 Global Hemostatic Forceps Revenue Market Share by Type (2019-2030)
4.3 Global Hemostatic Forceps Price by Type
4.3.1 Global Hemostatic Forceps Price by Type (2019-2024)
4.3.2 Global Hemostatic Forceps Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Hemostatic Forceps Sales Quantity by Application
5.1.1 Global Hemostatic Forceps Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Hemostatic Forceps Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Hemostatic Forceps Sales Quantity Market Share by Application (2019-2030)
5.2 Global Hemostatic Forceps Revenue by Application
5.2.1 Global Hemostatic Forceps Historical Revenue by Application (2019-2024)
5.2.2 Global Hemostatic Forceps Forecasted Revenue by Application (2025-2030)
5.2.3 Global Hemostatic Forceps Revenue Market Share by Application (2019-2030)
5.3 Global Hemostatic Forceps Price by Application
5.3.1 Global Hemostatic Forceps Price by Application (2019-2024)
5.3.2 Global Hemostatic Forceps Price Forecast by Application (2025-2030)
6 North America
6.1 North America Hemostatic Forceps Sales by Company
6.1.1 North America Hemostatic Forceps Revenue by Company (2019-2024)
6.1.2 North America Hemostatic Forceps Sales Quantity by Company (2019-2024)
6.2 North America Hemostatic Forceps Market Size by Type
6.2.1 North America Hemostatic Forceps Sales Quantity by Type (2019-2030)
6.2.2 North America Hemostatic Forceps Revenue by Type (2019-2030)
6.3 North America Hemostatic Forceps Market Size by Application
6.3.1 North America Hemostatic Forceps Sales Quantity by Application (2019-2030)
6.3.2 North America Hemostatic Forceps Revenue by Application (2019-2030)
6.4 North America Hemostatic Forceps Market Size by Country
6.4.1 North America Hemostatic Forceps Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Hemostatic Forceps Revenue by Country (2019-2030)
6.4.3 North America Hemostatic Forceps Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hemostatic Forceps Sales by Company
7.1.1 Europe Hemostatic Forceps Sales Quantity by Company (2019-2024)
7.1.2 Europe Hemostatic Forceps Revenue by Company (2019-2024)
7.2 Europe Hemostatic Forceps Market Size by Type
7.2.1 Europe Hemostatic Forceps Sales Quantity by Type (2019-2030)
7.2.2 Europe Hemostatic Forceps Revenue by Type (2019-2030)
7.3 Europe Hemostatic Forceps Market Size by Application
7.3.1 Europe Hemostatic Forceps Sales Quantity by Application (2019-2030)
7.3.2 Europe Hemostatic Forceps Revenue by Application (2019-2030)
7.4 Europe Hemostatic Forceps Market Size by Country
7.4.1 Europe Hemostatic Forceps Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Hemostatic Forceps Revenue by Country (2019-2030)
7.4.3 Europe Hemostatic Forceps Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Hemostatic Forceps Sales by Company
8.1.1 China Hemostatic Forceps Sales Quantity by Company (2019-2024)
8.1.2 China Hemostatic Forceps Revenue by Company (2019-2024)
8.2 China Hemostatic Forceps Market Size by Type
8.2.1 China Hemostatic Forceps Sales Quantity by Type (2019-2030)
8.2.2 China Hemostatic Forceps Revenue by Type (2019-2030)
8.3 China Hemostatic Forceps Market Size by Application
8.3.1 China Hemostatic Forceps Sales Quantity by Application (2019-2030)
8.3.2 China Hemostatic Forceps Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Hemostatic Forceps Sales by Company
9.1.1 APAC Hemostatic Forceps Sales Quantity by Company (2019-2024)
9.1.2 APAC Hemostatic Forceps Revenue by Company (2019-2024)
9.2 APAC Hemostatic Forceps Market Size by Type
9.2.1 APAC Hemostatic Forceps Sales Quantity by Type (2019-2030)
9.2.2 APAC Hemostatic Forceps Revenue by Type (2019-2030)
9.3 APAC Hemostatic Forceps Market Size by Application
9.3.1 APAC Hemostatic Forceps Sales Quantity by Application (2019-2030)
9.3.2 APAC Hemostatic Forceps Revenue by Application (2019-2030)
9.4 APAC Hemostatic Forceps Market Size by Region
9.4.1 APAC Hemostatic Forceps Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Hemostatic Forceps Revenue by Region (2019-2030)
9.4.3 APAC Hemostatic Forceps Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Hemostatic Forceps Sales by Company
10.1.1 Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Hemostatic Forceps Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Hemostatic Forceps Market Size by Type
10.2.1 Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Hemostatic Forceps Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Hemostatic Forceps Market Size by Application
10.3.1 Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Hemostatic Forceps Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Hemostatic Forceps Market Size by Country
10.4.1 Middle East, Africa and Latin America Hemostatic Forceps Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Hemostatic Forceps Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Medline
11.1.1 Medline Company Information
11.1.2 Medline Overview
11.1.3 Medline Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Medline Hemostatic Forceps Products and Services
11.1.5 Medline Hemostatic Forceps SWOT Analysis
11.1.6 Medline Recent Developments
11.2 B. Braun
11.2.1 B. Braun Company Information
11.2.2 B. Braun Overview
11.2.3 B. Braun Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 B. Braun Hemostatic Forceps Products and Services
11.2.5 B. Braun Hemostatic Forceps SWOT Analysis
11.2.6 B. Braun Recent Developments
11.3 CareFusion
11.3.1 CareFusion Company Information
11.3.2 CareFusion Overview
11.3.3 CareFusion Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 CareFusion Hemostatic Forceps Products and Services
11.3.5 CareFusion Hemostatic Forceps SWOT Analysis
11.3.6 CareFusion Recent Developments
11.4 Asa Dental
11.4.1 Asa Dental Company Information
11.4.2 Asa Dental Overview
11.4.3 Asa Dental Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Asa Dental Hemostatic Forceps Products and Services
11.4.5 Asa Dental Hemostatic Forceps SWOT Analysis
11.4.6 Asa Dental Recent Developments
11.5 Sklar
11.5.1 Sklar Company Information
11.5.2 Sklar Overview
11.5.3 Sklar Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Sklar Hemostatic Forceps Products and Services
11.5.5 Sklar Hemostatic Forceps SWOT Analysis
11.5.6 Sklar Recent Developments
11.6 Scanlan International
11.6.1 Scanlan International Company Information
11.6.2 Scanlan International Overview
11.6.3 Scanlan International Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Scanlan International Hemostatic Forceps Products and Services
11.6.5 Scanlan International Hemostatic Forceps SWOT Analysis
11.6.6 Scanlan International Recent Developments
11.7 Shanghai Medical Instruments
11.7.1 Shanghai Medical Instruments Company Information
11.7.2 Shanghai Medical Instruments Overview
11.7.3 Shanghai Medical Instruments Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Shanghai Medical Instruments Hemostatic Forceps Products and Services
11.7.5 Shanghai Medical Instruments Hemostatic Forceps SWOT Analysis
11.7.6 Shanghai Medical Instruments Recent Developments
11.8 Lawton
11.8.1 Lawton Company Information
11.8.2 Lawton Overview
11.8.3 Lawton Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.8.4 Lawton Hemostatic Forceps Products and Services
11.8.5 Lawton Hemostatic Forceps SWOT Analysis
11.8.6 Lawton Recent Developments
11.9 Hu-Friedy
11.9.1 Hu-Friedy Company Information
11.9.2 Hu-Friedy Overview
11.9.3 Hu-Friedy Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.9.4 Hu-Friedy Hemostatic Forceps Products and Services
11.9.5 Hu-Friedy Hemostatic Forceps SWOT Analysis
11.9.6 Hu-Friedy Recent Developments
11.10 Xinhua Surgical
11.10.1 Xinhua Surgical Company Information
11.10.2 Xinhua Surgical Overview
11.10.3 Xinhua Surgical Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.10.4 Xinhua Surgical Hemostatic Forceps Products and Services
11.10.5 Xinhua Surgical Hemostatic Forceps SWOT Analysis
11.10.6 Xinhua Surgical Recent Developments
11.11 Towne Brothers
11.11.1 Towne Brothers Company Information
11.11.2 Towne Brothers Overview
11.11.3 Towne Brothers Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.11.4 Towne Brothers Hemostatic Forceps Products and Services
11.11.5 Towne Brothers Recent Developments
11.12 Teleflex Medical
11.12.1 Teleflex Medical Company Information
11.12.2 Teleflex Medical Overview
11.12.3 Teleflex Medical Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.12.4 Teleflex Medical Hemostatic Forceps Products and Services
11.12.5 Teleflex Medical Recent Developments
11.13 Delacroix Chevalier
11.13.1 Delacroix Chevalier Company Information
11.13.2 Delacroix Chevalier Overview
11.13.3 Delacroix Chevalier Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.13.4 Delacroix Chevalier Hemostatic Forceps Products and Services
11.13.5 Delacroix Chevalier Recent Developments
11.14 YDM
11.14.1 YDM Company Information
11.14.2 YDM Overview
11.14.3 YDM Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.14.4 YDM Hemostatic Forceps Products and Services
11.14.5 YDM Recent Developments
11.15 M A Corporation
11.15.1 M A Corporation Company Information
11.15.2 M A Corporation Overview
11.15.3 M A Corporation Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.15.4 M A Corporation Hemostatic Forceps Products and Services
11.15.5 M A Corporation Recent Developments
11.16 MedGyn Products
11.16.1 MedGyn Products Company Information
11.16.2 MedGyn Products Overview
11.16.3 MedGyn Products Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.16.4 MedGyn Products Hemostatic Forceps Products and Services
11.16.5 MedGyn Products Recent Developments
11.17 Inami
11.17.1 Inami Company Information
11.17.2 Inami Overview
11.17.3 Inami Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.17.4 Inami Hemostatic Forceps Products and Services
11.17.5 Inami Recent Developments
11.18 Ted Pella
11.18.1 Ted Pella Company Information
11.18.2 Ted Pella Overview
11.18.3 Ted Pella Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.18.4 Ted Pella Hemostatic Forceps Products and Services
11.18.5 Ted Pella Recent Developments
11.19 Medicon eG
11.19.1 Medicon eG Company Information
11.19.2 Medicon eG Overview
11.19.3 Medicon eG Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.19.4 Medicon eG Hemostatic Forceps Products and Services
11.19.5 Medicon eG Recent Developments
11.20 J & J Instruments
11.20.1 J & J Instruments Company Information
11.20.2 J & J Instruments Overview
11.20.3 J & J Instruments Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.20.4 J & J Instruments Hemostatic Forceps Products and Services
11.20.5 J & J Instruments Recent Developments
11.21 American Diagnostic
11.21.1 American Diagnostic Company Information
11.21.2 American Diagnostic Overview
11.21.3 American Diagnostic Hemostatic Forceps Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.21.4 American Diagnostic Hemostatic Forceps Products and Services
11.21.5 American Diagnostic Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Hemostatic Forceps Value Chain Analysis
12.2 Hemostatic Forceps Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hemostatic Forceps Production Mode & Process
12.4 Hemostatic Forceps Sales and Marketing
12.4.1 Hemostatic Forceps Sales Channels
12.4.2 Hemostatic Forceps Distributors
12.5 Hemostatic Forceps Customers
13 Market Dynamics
13.1 Hemostatic Forceps Industry Trends
13.2 Hemostatic Forceps Market Drivers
13.3 Hemostatic Forceps Market Challenges
13.4 Hemostatic Forceps Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hemostatic Forceps Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Halstead Mosquito Hemostatic Forceps
Table 3. Major Manufacturers of Kelly and Crile Hemostatic Forceps
Table 4. Major Manufacturers of Rochester-Carmalt Hemostatic Forceps
Table 5. Global Hemostatic Forceps Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Hemostatic Forceps Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Hemostatic Forceps Revenue by Region (2019-2024) & (US$ Million)
Table 8. Global Hemostatic Forceps Revenue Market Share by Region (2019-2024)
Table 9. Global Hemostatic Forceps Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Hemostatic Forceps Revenue Market Share by Region (2025-2030)
Table 11. Global Hemostatic Forceps Sales Quantity by Region: 2019 VS 2023 VS 2030 (K Units)
Table 12. Global Hemostatic Forceps Sales by Region (2019-2024) & (K Units)
Table 13. Global Hemostatic Forceps Sales Market Share by Region (2019-2024)
Table 14. Global Hemostatic Forceps Sales by Region (2025-2030) & (K Units)
Table 15. Global Hemostatic Forceps Sales Market Share by Region (2025-2030)
Table 16. Global Hemostatic Forceps Sales Quantity by Manufacturers (2019-2024) & (K Units)
Table 17. Global Hemostatic Forceps Sales Quantity Share by Manufacturers (2019-2024)
Table 18. Global Hemostatic Forceps Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 19. Global Hemostatic Forceps Revenue Share by Manufacturers (2019-2024)
Table 20. Global Hemostatic Forceps Price by Manufacturers 2019-2024 (USD/Unit)
Table 21. Global Key Players of Hemostatic Forceps, Industry Ranking, 2022 VS 2023
Table 22. Global Hemostatic Forceps Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Hemostatic Forceps by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostatic Forceps as of 2023)
Table 24. Global Key Manufacturers of Hemostatic Forceps, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Hemostatic Forceps, Product Offered and Application
Table 26. Global Key Manufacturers of Hemostatic Forceps, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Hemostatic Forceps Sales Quantity by Type (2019-2024) & (K Units)
Table 29. Global Hemostatic Forceps Sales Quantity by Type (2025-2030) & (K Units)
Table 30. Global Hemostatic Forceps Sales Quantity Share by Type (2019-2024)
Table 31. Global Hemostatic Forceps Sales Quantity Share by Type (2025-2030)
Table 32. Global Hemostatic Forceps Revenue by Type (2019-2024) & (US$ Million)
Table 33. Global Hemostatic Forceps Revenue by Type (2025-2030) & (US$ Million)
Table 34. Global Hemostatic Forceps Revenue Share by Type (2019-2024)
Table 35. Global Hemostatic Forceps Revenue Share by Type (2025-2030)
Table 36. Hemostatic Forceps Price by Type (2019-2024) & (USD/Unit)
Table 37. Global Hemostatic Forceps Price Forecast by Type (2025-2030) & (USD/Unit)
Table 38. Global Hemostatic Forceps Sales Quantity by Application (2019-2024) & (K Units)
Table 39. Global Hemostatic Forceps Sales Quantity by Application (2025-2030) & (K Units)
Table 40. Global Hemostatic Forceps Sales Quantity Share by Application (2019-2024)
Table 41. Global Hemostatic Forceps Sales Quantity Share by Application (2025-2030)
Table 42. Global Hemostatic Forceps Revenue by Application (2019-2024) & (US$ Million)
Table 43. Global Hemostatic Forceps Revenue by Application (2025-2030) & (US$ Million)
Table 44. Global Hemostatic Forceps Revenue Share by Application (2019-2024)
Table 45. Global Hemostatic Forceps Revenue Share by Application (2025-2030)
Table 46. Hemostatic Forceps Price by Application (2019-2024) & (USD/Unit)
Table 47. Global Hemostatic Forceps Price Forecast by Application (2025-2030) & (USD/Unit)
Table 48. North America Hemostatic Forceps Revenue by Company (2019-2024) & (US$ Million)
Table 49. North America Hemostatic Forceps Sales Quantity by Company (2019-2024) & (K Units)
Table 50. North America Hemostatic Forceps Sales Quantity by Type (2019-2024) & (K Units)
Table 51. North America Hemostatic Forceps Sales Quantity by Type (2025-2030) & (K Units)
Table 52. North America Hemostatic Forceps Revenue by Type (2019-2024) & (US$ Million)
Table 53. North America Hemostatic Forceps Revenue by Type (2025-2030) & (US$ Million)
Table 54. North America Hemostatic Forceps Sales Quantity by Application (2019-2024) & (K Units)
Table 55. North America Hemostatic Forceps Sales Quantity by Application (2025-2030) & (K Units)
Table 56. North America Hemostatic Forceps Revenue by Application (2019-2024) & (US$ Million)
Table 57. North America Hemostatic Forceps Revenue by Application (2025-2030) & (US$ Million)
Table 58. North America Hemostatic Forceps Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 59. North America Hemostatic Forceps Revenue by Country (2019-2024) & (US$ Million)
Table 60. North America Hemostatic Forceps Revenue by Country (2025-2030) & (US$ Million)
Table 61. North America Hemostatic Forceps Sales Quantity by Country (2019-2024) & (K Units)
Table 62. North America Hemostatic Forceps Sales Quantity by Country (2025-2030) & (K Units)
Table 63. Europe Hemostatic Forceps Sales Quantity by Company (2019-2024) & (K Units)
Table 64. Europe Hemostatic Forceps Revenue by Company (2019-2024) & (US$ Million)
Table 65. Europe Hemostatic Forceps Sales Quantity by Type (2019-2024) & (K Units)
Table 66. Europe Hemostatic Forceps Sales Quantity by Type (2025-2030) & (K Units)
Table 67. Europe Hemostatic Forceps Revenue by Type (2019-2024) & (US$ Million)
Table 68. Europe Hemostatic Forceps Revenue by Type (2025-2030) & (US$ Million)
Table 69. Europe Hemostatic Forceps Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Europe Hemostatic Forceps Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Europe Hemostatic Forceps Revenue by Application (2019-2024) & (US$ Million)
Table 72. Europe Hemostatic Forceps Revenue by Application (2025-2030) & (US$ Million)
Table 73. Europe Hemostatic Forceps Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 74. Europe Hemostatic Forceps Revenue by Country (2019-2024) & (US$ Million)
Table 75. Europe Hemostatic Forceps Revenue by Country (2025-2030) & (US$ Million)
Table 76. Europe Hemostatic Forceps Sales Quantity by Country (2019-2024) & (K Units)
Table 77. Europe Hemostatic Forceps Sales Quantity by Country (2025-2030) & (K Units)
Table 78. China Hemostatic Forceps Sales Quantity by Company (2019-2024) & (K Units)
Table 79. China Hemostatic Forceps Revenue by Company (2019-2024) & (US$ Million)
Table 80. China Hemostatic Forceps Sales Quantity by Type (2019-2024) & (K Units)
Table 81. China Hemostatic Forceps Sales Quantity by Type (2025-2030) & (K Units)
Table 82. China Hemostatic Forceps Revenue by Type (2019-2024) & (US$ Million)
Table 83. China Hemostatic Forceps Revenue by Type (2025-2030) & (US$ Million)
Table 84. China Hemostatic Forceps Sales Quantity by Application (2019-2024) & (K Units)
Table 85. China Hemostatic Forceps Sales Quantity by Application (2025-2030) & (K Units)
Table 86. China Hemostatic Forceps Revenue by Application (2019-2024) & (US$ Million)
Table 87. China Hemostatic Forceps Revenue by Application (2025-2030) & (US$ Million)
Table 88. APAC Hemostatic Forceps Sales Quantity by Company (2019-2024) & (K Units)
Table 89. APAC Hemostatic Forceps Revenue by Company (2019-2024) & (US$ Million)
Table 90. APAC Hemostatic Forceps Sales Quantity by Type (2019-2024) & (K Units)
Table 91. APAC Hemostatic Forceps Sales Quantity by Type (2025-2030) & (K Units)
Table 92. APAC Hemostatic Forceps Revenue by Type (2019-2024) & (US$ Million)
Table 93. APAC Hemostatic Forceps Revenue by Type (2025-2030) & (US$ Million)
Table 94. APAC Hemostatic Forceps Sales Quantity by Application (2019-2024) & (K Units)
Table 95. APAC Hemostatic Forceps Sales Quantity by Application (2025-2030) & (K Units)
Table 96. APAC Hemostatic Forceps Revenue by Application (2019-2024) & (US$ Million)
Table 97. APAC Hemostatic Forceps Revenue by Application (2025-2030) & (US$ Million)
Table 98. APAC Hemostatic Forceps Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 99. APAC Hemostatic Forceps Revenue by Region (2019-2024) & (US$ Million)
Table 100. APAC Hemostatic Forceps Revenue by Region (2025-2030) & (US$ Million)
Table 101. APAC Hemostatic Forceps Sales Quantity by Region (2019-2024) & (K Units)
Table 102. APAC Hemostatic Forceps Sales Quantity by Region (2025-2030) & (K Units)
Table 103. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Company (2019-2024) & (K Units)
Table 104. Middle East, Africa and Latin America Hemostatic Forceps Revenue by Company (2019-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Type (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Type (2025-2030) & (K Units)
Table 107. Middle East, Africa and Latin America Hemostatic Forceps Revenue by Type (2019-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America Hemostatic Forceps Revenue by Type (2025-2030) & (US$ Million)
Table 109. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East, Africa and Latin America Hemostatic Forceps Revenue by Application (2019-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America Hemostatic Forceps Revenue by Application (2025-2030) & (US$ Million)
Table 113. Middle East, Africa and Latin America Hemostatic Forceps Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 114. Middle East, Africa and Latin America Hemostatic Forceps Revenue by Country (2019-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America Hemostatic Forceps Revenue by Country (2025-2030) & (US$ Million)
Table 116. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Country (2019-2024) & (K Units)
Table 117. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity by Country (2025-2030) & (K Units)
Table 118. Medline Company Information
Table 119. Medline Description and Overview
Table 120. Medline Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 121. Medline Hemostatic Forceps Product and Services
Table 122. Medline Hemostatic Forceps SWOT Analysis
Table 123. Medline Recent Developments
Table 124. B. Braun Company Information
Table 125. B. Braun Description and Overview
Table 126. B. Braun Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 127. B. Braun Hemostatic Forceps Product and Services
Table 128. B. Braun Hemostatic Forceps SWOT Analysis
Table 129. B. Braun Recent Developments
Table 130. CareFusion Company Information
Table 131. CareFusion Description and Overview
Table 132. CareFusion Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 133. CareFusion Hemostatic Forceps Product and Services
Table 134. CareFusion Hemostatic Forceps SWOT Analysis
Table 135. CareFusion Recent Developments
Table 136. Asa Dental Company Information
Table 137. Asa Dental Description and Overview
Table 138. Asa Dental Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 139. Asa Dental Hemostatic Forceps Product and Services
Table 140. Asa Dental Hemostatic Forceps SWOT Analysis
Table 141. Asa Dental Recent Developments
Table 142. Sklar Company Information
Table 143. Sklar Description and Overview
Table 144. Sklar Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 145. Sklar Hemostatic Forceps Product and Services
Table 146. Sklar Hemostatic Forceps SWOT Analysis
Table 147. Sklar Recent Developments
Table 148. Scanlan International Company Information
Table 149. Scanlan International Description and Overview
Table 150. Scanlan International Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 151. Scanlan International Hemostatic Forceps Product and Services
Table 152. Scanlan International Hemostatic Forceps SWOT Analysis
Table 153. Scanlan International Recent Developments
Table 154. Shanghai Medical Instruments Company Information
Table 155. Shanghai Medical Instruments Description and Overview
Table 156. Shanghai Medical Instruments Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 157. Shanghai Medical Instruments Hemostatic Forceps Product and Services
Table 158. Shanghai Medical Instruments Hemostatic Forceps SWOT Analysis
Table 159. Shanghai Medical Instruments Recent Developments
Table 160. Lawton Company Information
Table 161. Lawton Description and Overview
Table 162. Lawton Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 163. Lawton Hemostatic Forceps Product and Services
Table 164. Lawton Hemostatic Forceps SWOT Analysis
Table 165. Lawton Recent Developments
Table 166. Hu-Friedy Company Information
Table 167. Hu-Friedy Description and Overview
Table 168. Hu-Friedy Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 169. Hu-Friedy Hemostatic Forceps Product and Services
Table 170. Hu-Friedy Hemostatic Forceps SWOT Analysis
Table 171. Hu-Friedy Recent Developments
Table 172. Xinhua Surgical Company Information
Table 173. Xinhua Surgical Description and Overview
Table 174. Xinhua Surgical Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 175. Xinhua Surgical Hemostatic Forceps Product and Services
Table 176. Xinhua Surgical Hemostatic Forceps SWOT Analysis
Table 177. Xinhua Surgical Recent Developments
Table 178. Towne Brothers Company Information
Table 179. Towne Brothers Description and Overview
Table 180. Towne Brothers Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 181. Towne Brothers Hemostatic Forceps Product and Services
Table 182. Towne Brothers Recent Developments
Table 183. Teleflex Medical Company Information
Table 184. Teleflex Medical Description and Overview
Table 185. Teleflex Medical Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 186. Teleflex Medical Hemostatic Forceps Product and Services
Table 187. Teleflex Medical Recent Developments
Table 188. Delacroix Chevalier Company Information
Table 189. Delacroix Chevalier Description and Overview
Table 190. Delacroix Chevalier Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 191. Delacroix Chevalier Hemostatic Forceps Product and Services
Table 192. Delacroix Chevalier Recent Developments
Table 193. YDM Company Information
Table 194. YDM Description and Overview
Table 195. YDM Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 196. YDM Hemostatic Forceps Product and Services
Table 197. YDM Recent Developments
Table 198. M A Corporation Company Information
Table 199. M A Corporation Description and Overview
Table 200. M A Corporation Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 201. M A Corporation Hemostatic Forceps Product and Services
Table 202. M A Corporation Recent Developments
Table 203. MedGyn Products Company Information
Table 204. MedGyn Products Description and Overview
Table 205. MedGyn Products Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 206. MedGyn Products Hemostatic Forceps Product and Services
Table 207. MedGyn Products Recent Developments
Table 208. Inami Company Information
Table 209. Inami Description and Overview
Table 210. Inami Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 211. Inami Hemostatic Forceps Product and Services
Table 212. Inami Recent Developments
Table 213. Ted Pella Company Information
Table 214. Ted Pella Description and Overview
Table 215. Ted Pella Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 216. Ted Pella Hemostatic Forceps Product and Services
Table 217. Ted Pella Recent Developments
Table 218. Medicon eG Company Information
Table 219. Medicon eG Description and Overview
Table 220. Medicon eG Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 221. Medicon eG Hemostatic Forceps Product and Services
Table 222. Medicon eG Recent Developments
Table 223. J & J Instruments Company Information
Table 224. J & J Instruments Description and Overview
Table 225. J & J Instruments Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 226. J & J Instruments Hemostatic Forceps Product and Services
Table 227. J & J Instruments Recent Developments
Table 228. American Diagnostic Company Information
Table 229. American Diagnostic Description and Overview
Table 230. American Diagnostic Hemostatic Forceps Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2019-2024)
Table 231. American Diagnostic Hemostatic Forceps Product and Services
Table 232. American Diagnostic Recent Developments
Table 233. Key Raw Materials Lists
Table 234. Raw Materials Key Suppliers Lists
Table 235. Hemostatic Forceps Distributors List
Table 236. Hemostatic Forceps Customers List
Table 237. Hemostatic Forceps Market Trends
Table 238. Hemostatic Forceps Market Drivers
Table 239. Hemostatic Forceps Market Challenges
Table 240. Hemostatic Forceps Market Restraints
Table 241. Research Programs/Design for This Report
Table 242. Key Data Information from Secondary Sources
Table 243. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostatic Forceps Product Picture
Figure 2. Global Hemostatic Forceps Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hemostatic Forceps Market Share by Type in 2023 & 2030
Figure 4. Halstead Mosquito Hemostatic Forceps Product Picture
Figure 5. Kelly and Crile Hemostatic Forceps Product Picture
Figure 6. Rochester-Carmalt Hemostatic Forceps Product Picture
Figure 7. Global Hemostatic Forceps Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Hemostatic Forceps Market Share by Application in 2023 & 2030
Figure 9. Surgical
Figure 10. Dissection
Figure 11. Dental
Figure 12. Laparoscopic
Figure 13. Others
Figure 14. Hemostatic Forceps Report Years Considered
Figure 15. Global Hemostatic Forceps Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Hemostatic Forceps Revenue 2019-2030 (US$ Million)
Figure 17. Global Hemostatic Forceps Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 18. Global Hemostatic Forceps Sales Quantity 2019-2030 (K Units)
Figure 19. Global Hemostatic Forceps Sales Quantity Market Share by Region (2019-2024)
Figure 20. Global Hemostatic Forceps Sales Quantity Market Share by Region (2025-2030)
Figure 21. North America Hemostatic Forceps Sales Quantity YoY (2019-2030) & (K Units)
Figure 22. North America Hemostatic Forceps Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Europe Hemostatic Forceps Sales Quantity YoY (2019-2030) & (K Units)
Figure 24. Europe Hemostatic Forceps Revenue YoY (2019-2030) & (US$ Million)
Figure 25. China Hemostatic Forceps Sales Quantity YoY (2019-2030) & (K Units)
Figure 26. China Hemostatic Forceps Revenue YoY (2019-2030) & (US$ Million)
Figure 27. APAC Hemostatic Forceps Sales Quantity YoY (2019-2030) & (K Units)
Figure 28. APAC Hemostatic Forceps Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity YoY (2019-2030) & (K Units)
Figure 30. Middle East, Africa and Latin America Hemostatic Forceps Revenue YoY (2019-2030) & (US$ Million)
Figure 31. The Top 10 and Top 5 Players Market Share by Hemostatic Forceps Sales Quantity in 2023
Figure 32. The Top 10 and Top 5 Players Market Share by Hemostatic Forceps Revenue in 2023
Figure 33. Hemostatic Forceps Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 34. Global Hemostatic Forceps Sales Quantity Market Share by Type (2019-2030)
Figure 35. Global Hemostatic Forceps Revenue Market Share by Type (2019-2030)
Figure 36. Global Hemostatic Forceps Sales Quantity Market Share by Application (2019-2030)
Figure 37. Global Hemostatic Forceps Revenue Market Share by Application (2019-2030)
Figure 38. North America Hemostatic Forceps Revenue Market Share by Company in 2023
Figure 39. North America Hemostatic Forceps Sales Quantity Market Share by Company in 2023
Figure 40. North America Hemostatic Forceps Sales Quantity Market Share by Type (2019-2030)
Figure 41. North America Hemostatic Forceps Revenue Market Share by Type (2019-2030)
Figure 42. North America Hemostatic Forceps Sales Quantity Market Share by Application (2019-2030)
Figure 43. North America Hemostatic Forceps Revenue Market Share by Application (2019-2030)
Figure 44. North America Hemostatic Forceps Revenue Share by Country (2019-2030)
Figure 45. North America Hemostatic Forceps Sales Quantity Share by Country (2019-2030)
Figure 46. U.S. Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 47. Canada Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 48. Europe Hemostatic Forceps Sales Quantity Market Share by Company in 2023
Figure 49. Europe Hemostatic Forceps Revenue Market Share by Company in 2023
Figure 50. Europe Hemostatic Forceps Sales Quantity Market Share by Type (2019-2030)
Figure 51. Europe Hemostatic Forceps Revenue Market Share by Type (2019-2030)
Figure 52. Europe Hemostatic Forceps Sales Quantity Market Share by Application (2019-2030)
Figure 53. Europe Hemostatic Forceps Revenue Market Share by Application (2019-2030)
Figure 54. Europe Hemostatic Forceps Revenue Share by Country (2019-2030)
Figure 55. Europe Hemostatic Forceps Sales Quantity Share by Country (2019-2030)
Figure 56. Germany Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 57. France Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 58. U.K. Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 59. Italy Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 60. Russia Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 61. China Hemostatic Forceps Sales Quantity Market Share by Company in 2023
Figure 62. China Hemostatic Forceps Revenue Market Share by Company in 2023
Figure 63. China Hemostatic Forceps Sales Quantity Market Share by Type (2019-2030)
Figure 64. China Hemostatic Forceps Revenue Market Share by Type (2019-2030)
Figure 65. China Hemostatic Forceps Sales Quantity Market Share by Application (2019-2030)
Figure 66. China Hemostatic Forceps Revenue Market Share by Application (2019-2030)
Figure 67. APAC Hemostatic Forceps Sales Quantity Market Share by Company in 2023
Figure 68. APAC Hemostatic Forceps Revenue Market Share by Company in 2023
Figure 69. APAC Hemostatic Forceps Sales Quantity Market Share by Type (2019-2030)
Figure 70. APAC Hemostatic Forceps Revenue Market Share by Type (2019-2030)
Figure 71. APAC Hemostatic Forceps Sales Quantity Market Share by Application (2019-2030)
Figure 72. APAC Hemostatic Forceps Revenue Market Share by Application (2019-2030)
Figure 73. APAC Hemostatic Forceps Revenue Share by Region (2019-2030)
Figure 74. APAC Hemostatic Forceps Sales Quantity Share by Region (2019-2030)
Figure 75. Japan Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 76. South Korea Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 77. China Taiwan Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 78. Southeast Asia Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 79. India Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 80. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity Market Share by Company in 2023
Figure 81. Middle East, Africa and Latin America Hemostatic Forceps Revenue Market Share by Company in 2023
Figure 82. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity Market Share by Type (2019-2030)
Figure 83. Middle East, Africa and Latin America Hemostatic Forceps Revenue Market Share by Type (2019-2030)
Figure 84. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity Market Share by Application (2019-2030)
Figure 85. Middle East, Africa and Latin America Hemostatic Forceps Revenue Market Share by Application (2019-2030)
Figure 86. Middle East, Africa and Latin America Hemostatic Forceps Sales Quantity Share by Country (2019-2030)
Figure 87. Middle East, Africa and Latin America Hemostatic Forceps Revenue Share by Country (2019-2030)
Figure 88. Brazil Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 89. Mexico Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 90. Turkey Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 91. Israel Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 92. GCC Countries Hemostatic Forceps Revenue (2019-2030) & (US$ Million)
Figure 93. Hemostatic Forceps Value Chain
Figure 94. Hemostatic Forceps Production Process
Figure 95. Channels of Distribution (Direct Vs Distribution)
Figure 96. Distributors Profiles
Figure 97. Bottom-up and Top-down Approaches for This Report
Figure 98. Data Triangulation
Figure 99. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Hemostatic Forceps market size from 2024 to 2030?
The annual compound growth rate of the global Hemostatic Forceps market is 4.3% 2024 to 2030.
What was the global market size of Hemostatic Forceps in 2024?
Which companies rank high in the global Hemostatic Forceps market?
What was the global market size of Hemostatic Forceps in 2030?
Which region is expected to have the highest market share?
Related Reports
Global Hemostatic Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostatic Forceps market size was US$ 67.75 million in 2025 and is forecast to reach a readjusted size of US$ 90.6 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 115
USD 4250.00
(Single User License)
Global Hemostatic Forceps Market Research Report 2026
The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 138
USD 2900.00
(Single User License)
Hemostatic Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 163
USD 3950.00
(Single User License)
Global Hemostatic Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostatic Forceps market is projected to grow from US$ 65.2 million in 2024 to US$ 87.2 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 200
USD 4900.00
(Single User License)
Global Hemostatic Forceps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 181
USD 5900.00
(Single User License)
Global Hemostatic Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 111
USD 4250.00
(Single User License)
Hemostatic Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostatic Forceps was estimated to be worth US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 159
USD 3950.00
(Single User License)
Global Hemostatic Forceps Market Research Report 2025
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published Date: 2025-01-16
Pages: 117
USD 2900.00
(Single User License)
Global Hemostatic Forceps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-16
Pages: 186
USD 5900.00
(Single User License)
Global Hemostatic Forceps Market Insights, Forecast to 2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published Date: 2024-04-07
Pages: 129
USD 4900.00
(Single User License)
Global Hemostatic Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostatic Forceps market size was US$ 67.75 million in 2025 and is forecast to reach a readjusted size of US$ 90.6 million by 2032 with a CAGR of 4.3% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 115
USD 4250.00 (Single User License)Global Hemostatic Forceps Market Research Report 2026
The global Hemostatic Forceps market was valued at US$ 67.75 million in 2025 and is anticipated to reach US$ 90.6 million by 2032, at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 138
USD 2900.00 (Single User License)Hemostatic Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostatic Forceps was estimated to be worth US$ 67.75 million in 2025 and is projected to reach US$ 90.6 million, growing at a CAGR of 4.3% from 2026 to 2032.
Published: 2026-01-04
Pages: 163
USD 3950.00 (Single User License)Global Hemostatic Forceps Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostatic Forceps market is projected to grow from US$ 65.2 million in 2024 to US$ 87.2 million by 2031, at a CAGR of 4.3% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 200
USD 4900.00 (Single User License)Global Hemostatic Forceps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostatic Forceps was estimated to be worth US$ 65.2 million and is forecast to reach approximately US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 181
USD 5900.00 (Single User License)Global Hemostatic Forceps Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostatic Forceps market size was US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 111
USD 4250.00 (Single User License)Hemostatic Forceps- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostatic Forceps was estimated to be worth US$ 65.2 million in 2024 and is forecast to a readjusted size of US$ 87.2 million by 2031 with a CAGR of 4.3% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 159
USD 3950.00 (Single User License)Global Hemostatic Forceps Market Research Report 2025
The global market for Hemostatic Forceps was valued at US$ 65.2 million in the year 2024 and is projected to reach a revised size of US$ 87.2 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Published: 2025-01-16
Pages: 117
USD 2900.00 (Single User License)Global Hemostatic Forceps Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-16
Pages: 186
USD 5900.00 (Single User License)Global Hemostatic Forceps Market Insights, Forecast to 2030
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
Published: 2024-04-07
Pages: 129
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now